Sucampo Pharmaceuticals, developer of proprietary drugs based on prostones, filed for its IPO on Monday. Banc of America, Deutsche Bank and Leerink Swann & Company are managing the deal for the Bethesda, MD based company. Terms and timing have yet to be announced.
